08/11/2021
7:39 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2021
7:35 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2021
3:44 PM | Maranian Jeffrey R (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2021
3:39 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2021
3:34 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2021
3:15 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2021
3:32 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2021
3:39 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2021
3:37 PM | Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2021
8:41 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/29/2021
3:35 PM | Summit Therapeutics (Filer)
| Form DEF 14A
| |
04/22/2021
4:11 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
04/21/2021
7:14 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2021
6:55 AM | Summit Therapeutics (Filer)
| Form 424B4
| |
03/31/2021
3:50 PM | Summit Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2021
4:07 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
03/26/2021
3:46 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2021
6:12 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/02/2021
4:36 PM | Summit Therapeutics (Issuer)
Wang Luhua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2021
4:34 PM | Summit Therapeutics (Issuer)
Wang Luhua (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/02/2021
4:26 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2021
5:04 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:01 PM | Erdtmann Rainer M (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
4:59 PM | Donaldson Michael Paul (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
6:32 AM | Polar Capital Holdings Plc (Filed by)
Summit Therapeutics (Subject)
| Form SC 13G
| |
01/20/2021
3:36 PM | Summit Therapeutics (Filer)
| Form 424B4
| |
01/19/2021
11:16 PM | Summit Therapeutics (Filer)
| Form EFFECT
| |
01/08/2021
8:07 AM | Summit Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/01/2020
6:45 PM | Powell David Jonathan (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
6:51 PM | Powell David Jonathan (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
3:11 PM | Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
| Form SC 13D/A
| |
11/24/2020
5:12 PM | Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2020
4:13 PM | Summit Therapeutics (Filer)
| Form 8-K/A
| |
11/23/2020
3:21 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2020
3:44 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2020
3:13 PM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2020
4:25 PM | Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2020
4:20 PM | Summit Therapeutics (Issuer)
Zanganeh Maky (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/12/2020
9:02 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2020
9:02 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/10/2020
3:25 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/10/2020
3:20 PM | Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
| Form SC 13D/A
| |
11/06/2020
3:14 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2020
11:15 PM | Summit Therapeutics (Filer)
| Form EFFECT
| |
10/07/2020
6:47 PM | Graham Camilla (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2020
6:42 PM | Graham Camilla (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/06/2020
6:42 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2020
3:32 PM | Summit Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/05/2020
3:30 PM | Summit Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/05/2020
7:30 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2020
6:17 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2020
6:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2020
3:40 PM | Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
| Form SC 13D
| |
09/28/2020
3:37 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D
| |
09/18/2020
3:17 PM | Erdtmann Rainer M (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:17 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:17 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:16 PM | Houbiers Jos (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:14 PM | Donaldson Michael Paul (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:14 PM | Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:14 PM | Powell David Jonathan (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:13 PM | Stefanov Ventzislav (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:11 PM | Summit Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE
| |
09/18/2020
8:24 AM | Summit Therapeutics (Filer)
| Form 8-K12B
| |
09/17/2020
6:31 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2020
3:04 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/27/2020
3:06 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2020
7:59 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2020
7:39 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2020
6:37 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2020
7:08 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2020
1:38 PM | LANSDOWNE PARTNERS LLP (0001608485) (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
06/08/2020
7:14 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2020
4:13 PM | Summit Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/15/2020
9:18 AM | LANSDOWNE PARTNERS LLP (0001608485) (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
04/30/2020
8:22 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2020
8:22 AM | Summit Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/20/2020
3:05 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2020
4:03 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2020
1:59 PM | LANSDOWNE PARTNERS LLP (0001608485) (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
01/23/2020
4:27 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2020
1:33 PM | Summit Therapeutics (Subject)
Zanganeh Maky (Filed by)
| Form SC 13D
| |
01/16/2020
3:30 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
01/02/2020
3:39 PM | Summit Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/27/2019
3:32 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
12/26/2019
8:32 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2019
3:06 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2019
7:06 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2019
3:04 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A
| |
12/06/2019
3:31 PM | Summit Therapeutics (Filer)
| Form 6-K/A
| |
12/06/2019
8:49 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2019
6:50 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2019
6:44 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2019
3:19 PM | Summit Therapeutics (Filer)
| Form 424B3
| |
06/20/2019
11:15 PM | Summit Therapeutics (Filer)
| Form EFFECT
| |
06/19/2019
3:05 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2019
3:06 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2019
7:19 AM | Summit Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
06/12/2019
6:32 AM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2019
4:03 PM | Summit Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
